Pacific Edge cuts losses by $4.7m on US growth

Pacific Edge cuts losses by $4.7m on US growth
Total lab throughput for tests dipped 6% compared to the prior year.
Brent Melville
Cancer diagnostics firm Pacific Edge has slowed its cash burn on the strength of key wins in its core US market, trimming net losses after tax by a quarter, or $4.7 million, to $14.2m for the year to March.That came off a more than doubling in revenue to $10.4m from a comparable $5.2m in 2020, with operating revenue from test sales at $7.7m, driven by inroads into the commercialisation of its Cxbladder product into international markets.Chief executive David Darling said the result had been achieved despite headwinds created by covid particular...

More Markets

More than $1b traded on NZ sharemarket
Markets Market close

More than $1b traded on NZ sharemarket

Trading was extended as 335.4 million shares worth $1.93 billion changed hands.

Eroad posts loss in half-year speedbump
Markets

Eroad posts loss in half-year speedbump

A soft NZ dollar and economic pressures had a notable impact, but the CEOs are optimistic.

Radius Care's run continues as earnings jump 14%
Markets

Radius Care's run continues as earnings jump 14%

The small-cap aged care services company's shares have lifted 57% this year. 

Channel looks to raise $50m, inks deal with Fletcher subsidiary
Markets

Channel looks to raise $50m, inks deal with Fletcher subsidiary

Projects expected to deliver $120m in incremental revenue over 15-year period.